SENSEX NIFTY

Dr Reddys Laboratories

Aug 28, 2014 at 21:21 | Source: Moneycontrol.com
Sujana Universal Industries at its meeting held on August 28, 2014, has considered and approved the appointment of Dr. V. Malakonda Reddy as an Additional Director (Independent Director), under Section 149 & 161 of the Companies Act, 2013 and as Independent Non-Executive Chairman of the Board.
Aug 28, 2014 at 14:00 | Source: Moneycontrol.com
The Nifty closed above the 7950 on the expiry day for August derivative contracts, up 18.30 points at 7954.35. BHEL topped the buying list, up 4 percent followed by ITC, L&T, ICICI Bank, ONGC, Wipro, M&M, Dr Reddy's Labs and GAIL with 1-2 percent.
Aug 28, 2014 at 11:21 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com recommends buying Dr Reddy's Laboratories.
Aug 28, 2014 at 08:22 | Source: Moneycontrol.com
Indian ADRs ended higher on Wednesday. Tata Motors added 1.65 percent and Dr Reddy's Laboratories gained 0.75 percent.
Aug 27, 2014 at 12:00 | Source: Moneycontrol.com
Shares of Tata Motors, ONGC, Hindustan Unilever, Bajaj Auto and Dr Reddy's Labs were other prominent gainers while NTPC, BHEL and Sesa Sterlite fell 1-2 percent followed by HDFC Bank, Reliance Industries, Hindalco, Tata Steel and Coal India with 0.3-0.7 percent.
Aug 27, 2014 at 11:47 | Source: CNBC-TV18
Amit Gupta of ICICIdirect recommends buying Dr Reddy's Laboratories on declines and expects the stock to go beyond Rs 3000.
Aug 27, 2014 at 09:15 | Source: Moneycontrol.com
ICICI Bank, State Bank of India, ONGC, Tata Motors, Bharti Airtel, Dr Reddy's Labs and BHEL gained 1-1.5 percent whereas TCS, Infosys, HUL, GAIL and Wipro fell 0.2-0.6 percent.
Aug 27, 2014 at 08:23 | Source: Moneycontrol.com
Indian ADRs ended higher on Tuesday. Tata Motors advanced 1.16 percent and Dr Reddy's Laboratories gained nearly 2 percent.
Aug 26, 2014 at 15:25 | Source: Moneycontrol.com
According to a Quant report, most pharma companies continue to have strong ANDA filings pending for approval, which gives enough confidence of high long-term growth, subject to timely regulatory approval.
Aug 26, 2014 at 13:28 | Source: Moneycontrol.com
Caplin Point Laboratories Ltd has informed BSE that Dr. K. C. John is appointed as an Independent Director by the Board of the Company with effect from August 25, 2014.
Messages on Dr Reddys Laboratories »

BSE/NSE Announcer

Platinum Member

4003 Followers

Dr Reddys Labs  

Dr Reddys Laboratories has informed that the 30th Annual General Meeting (AGM) of the Company will be held on July 31, 2014.

10.28 PM Jul 7th

BSE/NSE Announcer

Platinum Member

4003 Followers

Dr Reddys Labs  

Dr Reddys Laboratories board meeting will be held on July 30, 2014, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2014 (Q1).

10.19 PM Jul 7th

BSE/NSE Announcer

Platinum Member

4003 Followers

Dr Reddys Labs  

Dr Reddys Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 30, 2014, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2014 (Q1).

7.50 PM Jul 7th

Market Statistician

Platinum Member

9742 Followers

Dr Reddys Labs  

At 15:14 hrs, Dr Reddys Laboratories was trading at Rs 2,726.85 up 1.80%, with a huge increase in its volume of shares traded. Till now over 48,238 shares were traded as compared to its 5-day average of 19,240 shares.

3.15 PM Jul 7th

Market Statistician

Platinum Member

9742 Followers

Dr Reddys Labs  

At 14:14 hrs, Dr Reddys Laboratories was trading at Rs 2,737.05 up 2.18%, with a huge increase in its volume of shares traded. Till now over 42,110 shares were traded as compared to its 5-day average of 19,240 shares.

2.15 PM Jul 7th

BSE/NSE Announcer

Platinum Member

4003 Followers

Dr Reddys Labs  

Dr Reddys Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

2.51 PM Jun 19th

BSE/NSE Announcer

Platinum Member

4003 Followers

Dr Reddys Labs  

Dr. Reddys Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company vide a circular resolution passed on June 15, 2014 has granted 95,428 stock options, exercisable at par value of Rs.5/- under "Dr. Reddys

2.24 PM Jun 16th

vivekananda
_1950

New Member

0 Follower

Lupin  

Rupee is getting stronger. Realisation in export value will come down. Competition from other companies like Aurobindo pharma, Dr. Reddy Laboratories, Glen Pharma, Cadilla Health Care is on the increase in most of the products through in some products it has got monopoly. - My target for Lupin

1.38 PM Jun 13th

MMB Messenger

Platinum Member

240652 Followers

Dr Reddys Labs  

Will you buy Dr Reddys Laboratories?

11.34 AM Jun 11th

Market Statistician

Platinum Member

9742 Followers

Dr Reddys Labs  

At 14:14 hrs, Dr Reddys Laboratories was trading at Rs 2,303.25 down 0.94%, with a huge increase in its volume of shares traded. Till now over 197,546 shares were traded as compared to its 5-day average of 25,833 shares.

2.15 PM Jun 5th

News across the web »
Aug 21, 2014 at 00:51 | Source: FirstPost
Jul 31, 2014 at 01:52 | Source: Economic Times
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.